BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1903192)

  • 21. [Comparative study of norplant-2 and levonorgestrel-releasing intrauterine devices].
    Wang SL
    Zhonghua Fu Chan Ke Za Zhi; 1990 Jul; 25(4):232-4, 253. PubMed ID: 2119982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of Norplant contraceptive implants on lactation and infant growth].
    Díaz S; Herreros C; Juez G; Peralta O; Croxatto HB
    Rev Chil Obstet Ginecol; 1985; 50(5):421-8. PubMed ID: 3939621
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.
    Ortiz ME; Croxatto HB
    Contraception; 2007 Jun; 75(6 Suppl):S16-30. PubMed ID: 17531610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sonographic demonstration of a levonorgestrel-releasing IUD (Mirena)].
    Zalel Y; Kreizer D; Soriano D; Achiron R
    Harefuah; 1999 Jul; 137(1-2):30-1, 86. PubMed ID: 10959272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intrauterine device in the present and future.
    Rivera R; Chi IC; Farr G
    Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The levonorgestrel intrauterine system in nulliparous women.
    Prager S; Darney PD
    Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrauterine contraception: benefits to patients.
    Mishell DR
    J Fam Pract; 2004 Sep; Suppl():S9-14. PubMed ID: 15508357
    [No Abstract]   [Full Text] [Related]  

  • 32. Intrauterine steroid contraceptives.
    Scholten PC; Christaens GC; Haspels AA
    Wien Med Wochenschr; 1987 Nov; 137(20-21):479-83. PubMed ID: 3131966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrauterine devices and adolescents.
    Gold MA; Johnson LM
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lost levonorgestrel IUD: diagnosis and therapy.
    Nitke S; Rabinerson D; Dekel A; Sheiner E; Kaplan B; Hackmon R
    Contraception; 2004 Apr; 69(4):289-93. PubMed ID: 15033403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():15-22. PubMed ID: 11336429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A comparative study on the antifertility action of levonorgestrel oxime and levonorgestrel].
    Liu CQ; Shen SR; Dai MZ; Zhu JY; Liu GM; Li LZ
    Yao Xue Xue Bao; 1988 Apr; 23(4):252-7. PubMed ID: 3140576
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of Norplant on mothers and infants in the postpartum period.
    Affandi B; Karmadibrata S; Prihartono J; Lubis F; Samil RS
    Adv Contracept; 1986 Dec; 2(4):371-80. PubMed ID: 3105266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine contraception.
    Vernon L; Brown V
    Nurs Stand; 1998 Oct 14-20; 13(4):49-52; quiz 55-6. PubMed ID: 9887792
    [No Abstract]   [Full Text] [Related]  

  • 40. Is antibiotic prophylaxis mandatory after the insertion of levonorgestrel-releasing intrauterine systemin order to decrease the risk of pelvic inflammatory disease?
    Munteanu O; Radulescu L; Bodean O; Cirstoiu C; Secara D; Cirstoiu M
    J Med Life; 2013; 6(4):459-61. PubMed ID: 24868262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.